As filed with the Securities and Exchange Commission on January 31, 2023
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
_______________________
SCHEDULE TO
_______________________
TENDER OFFER STATEMENT (Under Section 14(d)(1) or 13(e)(1)
of the Securities Exchange Act of 1934)
(Amendment No. 1)
_______________________
BNY Mellon Alcentra Global Multi-Strategy Credit Fund, Inc.
(Name of Issuer)
BNY Mellon Alcentra Global Multi-Strategy Credit Fund, Inc.
(Names of Filing Person(s) (Issuer))
Shares of Common Stock, Par Value $0.001 per share
(Title of Class of Securities)
26189T 104
(CUSIP Number of Class of Securities)
James Bitetto
BNY Mellon Investment Adviser, Inc.
240 Greenwich Street
New York, New York 10286
(212) 922-6400
(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications on Behalf of Filing Person(s))
_______________________
Copy to: |
David Stephens, Esq. Proskauer Rose LLP Eleven Times Square New York, New York 10036 |
_______________________
January 18, 2023
(Date Tender Offer First Published, Sent or Given to Security Holders)
| _____________________________________________________________________________________________________________________ | |
| [_] | Check the box if the filing relates solely to preliminary communications made before the commencement of a tender offer. |
Check the appropriate boxes below to designate any transactions to which the statement relates:
| [_] | third party tender offer subject to Rule 14d-1 |
| [X] | issuer tender offer subject to Rule 13e-4 |
| [_] | going-private transaction subject to Rule 13e-3 |
| [_] | amendment to Schedule 13D under Rule 13d-2 |
Check the following box if the filing is a final amendment reporting the results of the tender offer: [_]
Introductory Statement
This Supplement relates to the Issuer Tender Offer Statement on Schedule TO (the "Statement") originally filed on January 18, 2023 by BNY Mellon Alcentra Global Multi-Strategy Credit Fund, Inc., a Maryland corporation (the "Fund"), pursuant to Rule 13e-4 under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), in connection with an offer by the Fund (the "Offer") to repurchase 2.5% of its issued and outstanding shares of common stock as of December 31, 2022, par value $0.001 per share (the "Shares"), in exchange for cash at a price equal to the Fund's most recent quarter-end net asset value ("NAV") per Share—i.e., the NAV per Share determined as of December 31, 2022—upon the terms and subject to the conditions set forth in the Offer to Purchase, dated January 18, 2023 (the "Offer to Purchase"), and in the related Letter of Transmittal.
This Supplement dated January 31, 2023 to the Offer to Purchase is being filed to report a change in the portfolio management team.
Items 1 through 9 and 11
Except as amended herein, the information set forth in the Offer to Purchase and the related Letter of Transmittal is incorporated herein by reference in answer to Items 1 through 9 and 11 of Schedule TO.
Item 10
Not Applicable.
Item 12
(a)(1)(i) Offer to Purchase, dated January 18, 2023.1
(a)(1)(ii) Form of Letter of Transmittal.1
(a)(2) None.
(a)(3) Not Applicable.
(a)(4) Not Applicable.
(a)(5)(i) Press release issued on January 11, 2023.2
(a)(5)(ii) Supplement dated January 31, 2023 to Offer to Purchase.*
(b) Filing Fee Exhibit.*
(c) Not Applicable.
(d)(1) Management Agreement.3
(d)(2) Interim Sub-Investment Advisory Agreement.1
(d)(3) Custody Agreement.4
(d)(4) First Amendment to Custody Agreement.4
(d)(5) Second Amendment to Custody Agreement.4
(d)(6) Letter Agreement adding the Fund to Custody Agreement.4
(d)(7) Service Agreement for Transfer Agent Services.4
(d)(8) First Amendment to Service Agreement for Transfer Agent Services.4
(d)(9) Letter Agreement adding the Fund to Service Agreement for Transfer Agent Services.4
(e) None.
(f) None.
(g) None.
(h) None.
______________________________________
* Filed herewith.
| 1 | Incorporated by reference to the Fund's Schedule TO-I, as filed with the Securities and Exchange Commission ("SEC") on January 18, 2023. |
| 2 | Incorporated by reference to the Fund's Schedule TO-C, as filed with the SEC on January 11, 2023. |
| 3 | Incorporated by reference to the corresponding Exhibits to Pre-Effective Amendment No. 4 to the Fund's Registration Statement on Form N-2 (File No. 333-223418; 811-23330) (the "Registration Statement") filed with the SEC on August 27, 2019. |
| 4 | Incorporated by reference to the corresponding Exhibits to Pre-Effective Amendment No. 3 to the Registration Statement filed with the SEC on June 13, 2019. |
Item 13
Not Applicable.
SIGNATURE
After due inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
BNY Mellon Alcentra Global Multi-Strategy Credit Fund, Inc.
| By: | /s/ James Bitetto Name: James Bitetto Title: Secretary
Dated: January 31, 2023 |
Exhibit Index
(a)(5)(ii) Supplement dated January 31, 2023 to Offer to Purchase.
(b) Filing Fee Exhibit.